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Abstract
The O-allylphenyl (AP) anomeric moiety was investigated as a new leaving group that can be activated for chemical glycosylation
under a variety of conditions, through both direct and remote pathways. Differentiation between the two activation pathways was
achieved in a mechanistic study. The orthogonal-type activation of the AP moiety along with common thioglycosides allows for the
execution of efficient oligosaccharide assembly.

Introduction
Current knowledge about the key roles of carbohydrates is still
limited. However, thanks to the explosive growth of the field of
glycobiology in recent years, we have already learned that
carbohydrates are involved in a broad range of vital biological
processes (e.g., fertilization, anti-inflammation, immunoresponse, joint lubrication, antigenic determination) [1]. Carbohydrates are also involved in many harmful processes (e.g.,
bacterial and viral infections, development of tumors, metastasis, tissue rejection, congenital disorders). The fact that many
of these processes are directly associated with the pathogenesis
of deadly diseases, including AIDS, cancer, pneumonia,
septicemia, hepatitis and malaria [2-4], has been particularly

stimulating for major scientific efforts in the field of modern
glycosciences. The traditional chemical synthesis of oligosaccharides is lengthy because it involves multiple manipulations of protecting and/or leaving groups between glycosylation
steps [5]. Many advanced strategies that shorten the oligosaccharide assembly by minimizing or even eliminating
additional manipulations between coupling steps, are based
either on chemoselective or on selective activation of leaving
groups [6]. The use of selective activation [7] offers more
flexibility than that of the chemoselective activation which
relies on the nature of the protecting groups [8], and Ogawa’s
orthogonal strategy is conceptually the most attractive approach
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Scheme 1: Orthogonal strategy introduced by Ogawa et al.

that has been developed to date [9-12]. This technique implies
the use of two orthogonal leaving groups, LGa and LGb, the
selective activation of which can be reiterated to give streamlined access to oligosaccharides (Scheme 1).

ible approach for oligosaccharide synthesis. Concomitantly with
our studies, Hung et al. came up with essentially the same idea
and reported the synthesis of AP mannosides and their activation for O-mannosylation in the presence of ICl/AgOTf [27].

Yet, the orthogonal strategy remains underdeveloped, with too
few examples to become universally applicable. Only Ogawa’s
S-phenyl (SPh) versus fluoride [9,10,13] and our thioimidatebased approaches [14-16] are known. A very promising orthogonality was shown for O-pentenyl versus O-propargyl glycosides by Hotha et al. [17] and for S-glycosyl O-methyl phenylcarbamothioate (SNea) versus thioglycosides/thioimidates by us
[18], but still their applicability to multistep synthesis remains
to be proven. Working to expand this concept, our group
reported a related, albeit less flexible, semiorthogonal approach
with the use of S-ethyl and O-pentenyl leaving groups [19],
which was later extended to fluoride/O-pentenyl combination
by Fraser-Reid and Lopez [20]. Oxygen- [21] and sulfur-based
[22] leaving groups fit into many expeditious strategies for
oligosaccharide synthesis [6]. However, suitable reaction conditions for the orthogonal activation of these two classes of
leaving groups are yet to be found. Commonly, O-glycosides
are too stable to be used as effective glycosyl donors [21]. Pent4-enyl O-glycosides introduced by Fraser-Reid are unique in
this category of leaving groups, because they can be glycosidated under mild conditions by using I+ generated in situ. Also
this method has its limitations since I+ can also activate thioglycosides. Indeed, only the semiorthogonality of the O-pentenyl
and SEt leaving groups could be established [19]. Additionally,
4-pentenol is rather expensive ($ 323/50 g, Aldrich), and
although O-pentenyl can be introduced from the anomeric
acetate directly, the most economical synthesis includes a threestep protocol, with halide, orthoester, and the rearrangement of
the latter to glycoside.

The following considerations driving our efforts were of particular relevance. First, chemists have been making aryl glycosides for some 130 years [28], and many excellent protocols for
their synthesis are available [29]. We determined that AP glycosides can be readily obtained from the corresponding peracetate
by using inexpensive 2-allylphenol ($ 35/100 g, Aldrich) in the
presence of BF3·Et2O. For instance, acetylated AP β-D-glucopyranoside was obtained in 92% yield. Second, we anticipated
that the same promoters used for O-pentenyl activation [30] can
also activate the AP leaving group. However, since AP glycosides bear structural features of both aryl and pentenyl glycosides, they should offer a more versatile activation profile than
either class of the leaving group. Our working hypothesis is that
activation of the AP leaving group with I+ takes place by the
formation of an epi-iodonium ion, which is then opened with
the anomeric oxygen, similarly to that known for O-pentenyl
glycosides [30]. It is possible that the activation of the AP
leaving group can also be achieved with TMSOTf or BF3·Et2O
via the direct anomeric activation pathway, which was expected
to become the key feature of the AP-mediated glycosylation
approach in comparison to that of both O-pentenyl or thioglycosides. As a result, this pathway may offer a suitable platform for
developing a fully orthogonal approach in combination with
thioglycosides.

Results and Discussion
As a part of the ongoing research effort to develop versatile
building blocks, we present herein the development of a new
ortho-allylphenyl (AP) leaving group. In line with other efforts
[23-26], the AP group was specifically designed to address the
drawbacks of O-pentenyl glycosides and to create a more flex-

To pursue this methodology we obtained a range of differently
protected AP glucosides, including perbenzylated 1a, perbenzoylated 1b, and derivative 1c equipped with the superarming
protecting-group pattern (2-O-benzoyl-3,4,6-tri-O-benzyl) [31].
For comparison, we also obtained the AP donor 1d of the
D-galacto series. With glycosyl donors 1a–d in hand, we began
evaluating their applicability to chemical glycosylation using a
range of standard glycosyl acceptors 2–5 [18]. Encouragingly,
the reaction of glycosyl donor 1a with the primary glycosyl
acceptor 2 in the presence of TMSOTf was completed within
15 min and provided the corresponding disaccharide 6a in 82%
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yield (Table 1, entry 1). As expected, when a control experiment was set up with MeOTf, no glycosylation of 2 took place
(Table 1, entry 2). The fact that the AP group in 1a can be activated with TMSOTf, but not with MeOTf, offers a basis for

exploring its orthogonality to thioglycosides. This is because
thioglycosides show a completely opposite reactivity trend,
namely no reaction with TMSOTf and smooth glycosylation
with MeOTf [32].

Table 1: Glycosylation of AP glycosyl donors 1a–d.

entry

donor + acceptor

conditionsa

time

product (yield, α/β ratio)

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20

1a + 2
1a + 2
1a + 2
1a + 2
1a + 3
1a + 4
1a + 5
1b + 2
1b + 2
1b + 2
1b + 2
1b + 5
1c + 2
1c + 2
1c + 2
1c + 2
1d + 2
1d + 3
1d + 4
1d + 5

TMSOTf, rt
MeOTf, rt
NIS/TMSOTf, 0 °C
NIS/TfOH, 0 °C
NIS/TfOH, 0 °C
NIS/TfOH, 0 °C
NIS/TfOH, 0 °C
MeOTf, rt
TMSOTf, rt
NIS/TMSOTf, 0 °C
NIS/TfOH, 0 °C
NIS/TfOH, 0 °C
MeOTf, rt
TMSOTf, −20 °C
NIS/TMSOTf, 0 °C
NIS/TfOH, −20 °C
NIS/TfOH, 0 °C
NIS/TfOH, 0 °C
NIS/TfOH, 0 °C
NIS/TfOH, 0 °C

15 min
24 h
40 min
15 min
4h
30 min
3h
24 h
24 h
6h
2h
3h
24 h
2.5 h
10 min
15 min
15 min
4h
30 min
2h

6a (82%, 2.7/1)
no reaction
6a (80%, 1.4/1)
6a (90%, 1/1.5)
7a (73%, 1.2/1)
8a (82%, 1.0/1)
9a (72%, 1/1.3)
no reaction
no reaction
6b (77%, β only)
6b (71%, β only)
9b (78%, β only)
no reaction
6c (73%, β only)
6c (84%, β only)
6c (93%, β only)
6d (85%, 1.5/1)
7d (81%, 1.2/1)
8d (82%, 1.0/1)
9d (80%, 3.0/1)

aperformed

in the presence of molecular sieves 4 Å (or 3 Å in MeOTf-promoted reactions, entries 2, 8, and 13).
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NIS/TMSOTf is a powerful promoter for the activation of
both O-pentenyl and thioglycosides. It was also found to
be effective for the activation of AP glycosyl donor 1a,
upon which disaccharide 6a was obtained in 80% yield.
Even faster reaction and higher yield was obtained by
using the NIS/TfOH promoter system, wherein the resulting
disaccharide 6a was obtained in 90% yield (Table 1, entry 4).
The latter reaction conditions were chosen for use in the investigation of the glycosylation of the secondary glycosyl acceptors
3–5.
These couplings were also proven to be feasible, and the corresponding disaccharides 7a–9a were obtained in 72–82% yield
(Table 1, entries 5–7). As anticipated, the reactivity of the
perbenzoylated (disarmed) counterpart 1b was significantly
lower than that of 1a, and TMSOTf-promoted glycosylation of
1b was practically ineffective (Table 1, entry 9). This observation along with the fact that the armed AP leaving group in 1a
can be readily activated with TMSOTf (Table 1, entry 1)
suggests that AP glycosides can be applied in accordance with
the classic armed–disarmed strategy [33]. NIS-promoted glycosylations of 1b have proven to be of preparative value and the
desired disaccharides 6b and 9b were isolated in 71–78% yield
(Table 1, entries 10–12). In order to gain a more flexible activation profile for the synthesis of 1,2-trans glycosides, we also
investigated AP glycosyl donor 1c, bearing a superarming
protecting-group pattern [31]. As expected, all of the previously established activation conditions were very effective, and
glycosylation of 1c with acceptor 2 readily produced
disaccharide 6c (Table 1, entries 14–16). Again, particularly
efficient was the NIS/TfOH-promoted reaction wherein
disaccharide 6c was isolated in 93% yield (Table 1, entry 16).
To broaden the scope of the AP approach, we tested its applicability to the synthesis of D-galactosides, which are a highly
important and abundant sugar series. All glycosylations of AP
donor 1d proceeded smoothly in the presence of NIS/TfOH and
the corresponding disaccharides 6d–9d were obtained in
80–85% yield (Table 1, entries 17–20). To verify the two anticipated activation pathways by which the AP group may depart,
all components of the key experiments (Table 1, entries 1 and 3)
wherein glycosyl donor 1a reacted with glycosyl acceptor 2 in
the presence of TMSOTf and NIS/TMSOTf, respectively, were
separated and analyzed. In the TMSOTf-promoted reaction,
(o-allylphenoxy)trimethylsilane (10) was isolated and identified by comparison with analytical data obtained from a
commercial sample. This result suggests that the activation of
the AP moiety with TMSOTf takes place through the anomeric
oxygen atom (A, Pathway A, Scheme 2). In the NIS/TMSOTfpromoted reaction, 2-iodomethyl-2,3-dihydrobenzofuran (11)
[34] was isolated and its identity was proven by spectral
methods indicating that activation with I+ takes place through

the remote allyl moiety (B, Pathway B). In addition, in the latter
experiment we detected the presence of adduct 12, which was
formed as the result of a competing attack of the glycosyl
acceptor oxygen, as opposed to endocyclization of B
through the anomeric oxygen leading to oxacarbenium intermediate C.
In accordance with Fraser-Reid’s armed–disarmed approach,
electronically activated (armed) glycosyl donors are chemoselectively activated over deactivated (disarmed) glycosyl acceptors bearing the same type of leaving group [30,35]. To explore
this avenue, we obtained a disarmed (benzoylated) 6-OH AP
glycosyl acceptor 13 (Supporting Information File 1), which
was coupled with the armed AP glycosyl donor 1a in the presence of TMSOTf. As anticipated, this reaction was feasible and
the expected disaccharide 14 was obtained in 78% yield
(Table 2, entry 1). With the ultimate goal of developing distinct
orthogonal differentiation of AP and thioglycosides, we next
obtained glycosyl acceptor 15 [36] equipped with an ethylthio
leaving group. TMSOTf-promoted chemoselective glycosylation between building blocks 1a and 15 produced the expected
disaccharide 16 in 71% yield (Table 2, entry 2).
In a selective activation fashion, glycosyl acceptors 17 [37] and
19 [38], equipped with S-tolyl (STol) and S-phenyl leaving
groups, respectively, were glycosylated with AP glycosyl donor
1a to afford disaccharides 18 and 20 in 75 and 90% yield, respectively (Table 2, entries 3 and 4). Also the disarmed SPh
acceptor 21 [39] led to disaccharide 22 in 98% yield. The synthesis of a 1,2-trans-linked disaccharide was also possible with
glycosyl donor 1c leading to the corresponding β-linked disaccharide 23 in 75% yield (Table 2, entry 6). This series of experiments clearly demonstrates that the AP leaving group can be
reliably activated with TMSOTf in the presence of S-alkyl/aryl
leaving groups. We next investigated glycosyl acceptor 25
equipped with the AP leaving group. MeOTf-promoted
glycosylation of SEt, STaz, STol, and SPh glycosyl donors 24
[40], 27 [14], 28 [41], and 29 [42], respectively, with acceptor
25 afforded the respective disaccharide 26 in 78–97% yield
(Table 2, entries 7–10). These series of results indicates a
completely orthogonal character of AP and the thioglycosides.
To expand this observation, disaccharide 26 was coupled with
thioglycoside acceptor 21 in the presence of TMSOTf leading
to trisaccharide 30 in 90% (Scheme 3). Since 30 is equipped
with the SPh anomeric leaving group, it is available for further
chain elongation directly. In a similar fashion, thioglycoside
disaccharide 16 was coupled with AP acceptors 25 and 13 in the
presence of MeOTf to afford trisaccharides 31 and 32 in 50 and
80% yield, respectively. Since these trisaccharides are equipped
with the AP leaving group, their direct application to further
chain elongation can be envisaged.
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Scheme 2: Determination of the AP activation pathways.

Table 2: AP glycosides as glycosyl donors and acceptors in chemoselective and selective activations.

entry

1
2
3
4
5
6

donor;
acceptor
1a (LG1 = OAP, R1 = R2 = Bn);
13 (LG2 = OAP, R3 = Bz)
1a;
15 (LG2 = SEt, R3 = Bn)
1a;
17(LG2 = STol, R3 = Bz)
1a;
19 (LG2 = SPh, R3 = Bn)
1a;
21 (LG2 = SPh, R3 = Bz)
1c (LG1 = OAP, R1 = Bz, R2 = Bn);
21

promotera

time

product (yield, α/β ratio)

A

10 min

14 (78%, 1.0/1)

A

15 min

16 (71%, 1.0/1)

A

1h

18 (75%, 2.4/1)

A

1h

20 (90%, 1.0/1)

A

2h

22 (98%, 1.8/1)

A

30 min

23 (75%, β only)
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Table 2: AP glycosides as glycosyl donors and acceptors in chemoselective and selective activations. (continued)

24 (LG1 = SEt, R1 = R2 = Bn);
25 (LG2 = OAP, R3 = Bn)
27 (LG1 = STaz, R1 = R2 = Bn);
25
28 (LG1 = STol, R1 = R2 = Bn);
25
29 (LG1 = SPh, R1 = R2 = Bn);
25

7
8
9
10
aperformed

B

2h

26 (82%, 1.8/1)

B

1h

26 (78%, 1.0/1)

B

4h

26 (97%, 1.2/1)

B

6h

26 (90%, 1.0/1)

in the presence of molecular sieves 4 Å (A: TMSOTf) or 3 Å (B: MeOTf) at rt or 0 °C (entry 6).

Scheme 3: AP building blocks in oligosaccharide synthesis.

Conclusion
In conclusion, we investigated the O-allylphenyl (AP) anomeric
moiety as a new leaving group that can be activated for chemical glycosylation under a variety of conditions including Lewis
acid and iodonium ion mediated pathways. The two activation
pathways were confirmed by a mechanistic study. We also
demonstrated that the application of the AP moiety allows
executing oligosaccharide assembly by an orthogonal concept.
The application of the AP glycosides may stretch well beyond
their initial intended purpose because the alkene moiety can be
utilized in a variety of other modes. Similar to that of
O-pentenyl [30], it can be temporarily deactivated toward the I+
activation pathway by the addition of Br 2 , which can be
reverted as needed (active–latent strategy). Direct conjugation

of the AP moiety to biomolecules, monolayers, arrays, etc.,
should be possible by executing thiol–ene chemistry [43],
ozonolysis/reductive amination [44-46], or other ligation protocols [47,48].

Experimental
General remarks
Column chromatography was performed on silica gel 60
(EM Science, 70–230 mesh), reactions were monitored by TLC
on Kieselgel 60 F 254 (EM Science). The compounds were
detected by examination under UV light and by charring
with 10% sulfuric acid in methanol. Solvents were removed
under reduced pressure at <40 °C. CH2Cl2 and ClCH2CH2Cl
were distilled from CaH 2 , directly prior to application.
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Anhydrous DMF (EM Science) was used as received.
Methanol was dried by heating under reflux with magnesium
methoxide, distilled and stored under argon. Pyridine and
acetonitrile were dried by heating under reflux with
CaH2 and then distilled and stored over molecular sieves (3 Å).
Molecular sieves (3 Å or 4 Å), used for reactions, were
crushed and activated in vacuo at 390 °C during 8 h in the first
instance and then for 2–3 h at 390 °C directly prior to
application. DOWEX MONOSPHERE 650C (H) was washed
three times with MeOH and stored under MeOH. Optical
rotations were measured with a Jasco P-1020 polarimeter.
1 H NMR spectra were recorded in CDCl at 300 MHz;
3
13C NMR spectra were recorded in CDCl at 75 MHz (Bruker
3
Avance) or 125 MHz (Varian). Anomeric ratios were determined by comparison of the integral intensities of the respective groups of signals in the 1H NMR spectra. HRMS determinations were made with the use of a JEOL MStation (JMS-700)
mass spectrometer.

Synthesis of glycosides
Typical MeOTf-promoted glycosylation procedure
(Method A). A mixture of glycosyl donor (0.11 mmol),
glycosyl acceptor (0.10 mmol), and freshly activated molecular
sieves (3 Å, 300 mg) in 1,2-dichloroethane (1.4 mL) was stirred
under argon for 1 h. MeOTf (0.33 mmol) was added and the
reaction mixture was monitored by TLC. Upon completion
(Table 1, Table 2), the solid was filtered off and the residue was
rinsed with CH2Cl2. The combined filtrate (30 mL) was washed
with 20% aq NaHCO3 (10 mL) and water (3 × 10 mL). The
organic layer was separated, dried with MgSO4 and concentrated in vacuo. The residue was purified by silica gel column
chromatography (ethyl acetate/hexanes gradient elution) to
afford the corresponding oligosaccharide.
Typical TMSOTf-promoted glycosylation procedure
(Method B). A mixture of glycosyl donor (0.11 mmol),
glycosyl acceptor (0.10 mmol), and freshly activated molecular
sieves (4 Å, 150 mg) in 1,2-dichloroethane (1.6 mL) was stirred
under argon for 1 h. TMSOTf (0.22 mmol) was added and the
reaction mixture was monitored by TLC. Upon completion
(Table 1, Table 2), the solid was filtered off and the residue was
rinsed with CH2Cl2. The combined filtrate (30 mL) was washed
with 20% aq NaHCO3 (10 mL) and water (3 × 10 mL). The
organic layer was separated, dried with MgSO4 and concentrated in vacuo. The residue was purified by silica gel column
chromatography (ethyl acetate/hexanes gradient elution) to
afford the corresponding oligosaccharide.

sieves (4 Å, 150 mg) in 1,2-dichloroethane (1.6 mL) was stirred
under argon for 1 h. NIS (0.22 mmol) and TfOH (0.022 mmol)
were added and the reaction mixture was monitored by TLC.
Upon completion, the mixture was diluted with CH2Cl2, the
solid was filtered off, and the residue was rinsed with CH2Cl2.
The combined filtrate (30 mL) was washed with 10% aq
Na2S2O3 (10 mL) and water (3 × 10 mL). The organic layer
was separated, dried with MgSO4 and concentrated in vacuo.
The residue was purified by silica gel column chromatography
(ethyl acetate/hexanes gradient elution) to afford the corresponding oligosaccharide.
Typical NIS/TMSOTf-promoted glycosylation procedure
(Method D). A mixture of glycosyl donor (0.11 mmol),
glycosyl acceptor (0.10 mmol), and freshly activated molecular
sieves (4 Å, 150 mg) in 1,2-dichloroethane (1.6 mL) was stirred
under argon for 1 h. NIS (0.22 mmol) and TMSOTf
(0.022 mmol) were added and the reaction mixture was monitored by TLC. Upon completion, the mixture was diluted with
CH2Cl2, the solid was filtered off, and the residue was rinsed
with CH2Cl2. The combined filtrate (30 mL) was washed with
10% aq Na2S2O3 (10 mL) and water (3 × 10 mL). The organic
layer was separated, dried with MgSO4 and concentrated in
vacuo. The residue was purified by silica gel column chromatography (ethyl acetate/hexanes gradient elution) to afford the
corresponding oligosaccharide.

Supporting Information
Supporting Information File 1
Experimental procedures, extended experimental data,
1H and 13C NMR spectra for all new compounds.
[http://www.beilstein-journals.org/bjoc/content/
supplementary/1860-5397-8-66-S1.pdf]
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